Nintedanib 150 MG: An Intracellular Inhibitor of Tyrosine Kinases

Marykudro21 Mar, 2022Health

Capsules of Nintedanib 150 mg are not approved for use by anyone aged younger than 18 years. It should not be used by patients who are breastfeeding. The nintedanib 150 mg is used to treat Idiopathic Pulmonary Fibrosis (IPF), chronic (long lasting) interstitial lung disease in which the scar tissue keeps getting worse, and used to resist the decline in lung function in individuals with a disorder named systemic sclerosis-associated interstitial lung disease (sometimes named scleroderma-associated ILD). Nintedanib can be responsible for causing severe diarrhea, which may be life-threatening in case it leads to dehydration. Patients may need to take medicine for the prevention of diarrhea. Kindly connect at TOLL-FREE No: 1800 889 1064 or Call/WhatsApp on (+91) 8130290915 or Email us on [email protected] to purchase this medication.